AHCA/NCAL: Join the Fight – Monoclonal Antibody Therapeutics for High-Risk COVID-19 Positive Residents

COVID-19 and its variants are once again plaguing the country as we see case counts rise once again. The COVID-19 vaccine is critical in slowing the spread. In addition to the vaccine, once a person is infected with COVID-19 and are considered high-risk, the focus should turn to treatment using monoclonal antibodies and therapeutics.

The Health and Human Services Office of the Assistant Secretary for Preparedness and Response has updated the CombatCOVID website with new resources to support providers in the fight against COVID-19.

Other COVID-19 Updates

New Updates to Regulatory and Agency COVID-19 Guidelines: With the Delta variant spreading rampantly throughout the U.S., AHCA/NCAL wants to keep members informed of the recent COVID-19 regulatory and Agency updates. Read More

How to Boost Your Staff Vaccination Rates Webinar: With the new delta variant quickly spreading in the United States, it is more important than ever to increase staff vaccination rates in LTC. Read More

Disability Nondiscrimination Laws Now Support People with Long COVID: This week on the 31st anniversary of the Americans with Disabilities Act, HHS and the Department of Justice jointly published guidance on how disability nondiscrimination laws apply to people with “long COVID.” Read More

GAO Releases Report on COVID-19 Relief Funds: The GAO released a new report, COVID-19:Continued Attention Needed to Enhance Federal Preparedness, Response, Service Delivery, and Program Integrity (GAO-21-551). Read More

AHCA/NCAL: Join the Fight – Monoclonal Antibody Therapeutics for High-Risk COVID-19 Positive Residents

Stay Connected!

In this Issue...

Education & Events

References & Resources